The estimated Net Worth of Janet Moore is at least 201 千$ dollars as of 4 January 2017. Ms. Moore owns over 9,000 units of Biomerica stock worth over 45,163$ and over the last 11 years she sold BMRA stock worth over 0$. In addition, she makes 155,643$ as Treasurer、 Secretary、 Director at Biomerica.
Janet has made over 6 trades of the Biomerica stock since 2014, according to the Form 4 filled with the SEC. Most recently she exercised 9,000 units of BMRA stock worth 3,870$ on 4 January 2017.
The largest trade she's ever made was exercising 35,000 units of Biomerica stock on 9 May 2016 worth over 14,000$. On average, Janet trades about 4,700 units every 63 days since 2013. As of 4 January 2017 she still owns at least 145,220 units of Biomerica stock.
You can see the complete history of Ms. Moore stock trades at the bottom of the page.
Janet Moore is no longer serves as Treasurer, Secretary, Director of the Company effective 12/10/2020. Ms. Janet Moore has been a Director of the Company since April 29, 1997, and has been serving as the Company's Secretary and Treasurer since 1985. She has served as the Company's Chief Financial Officer since 1999 and has been an employee of the Company since 1976. From fiscal 1998 through 2008, Ms. Moore also served as a director and Secretary of Lancer Orthodontics, Inc.
As the Treasurer、 Secretary、 Director of Biomerica, the total compensation of Janet Moore at Biomerica is 155,643$. There are 2 executives at Biomerica getting paid more, with Zackary Irani having the highest compensation of 330,481$.
Janet Moore is 68, she's been the Treasurer、 Secretary、 Director of Biomerica since 2020. There are 1 older and 9 younger executives at Biomerica. The oldest executive at Biomerica Inc. is Francis Cano, 76, who is the Independent Director.
Janet's mailing address filed with the SEC is 17571 Von Karman Ave, Irvine, CA 92614, USA.
Over the last 12 years, insiders at Biomerica have traded over 80,900$ worth of Biomerica stock and bought 151,277 units worth 334,788$ . The most active insiders traders include Mark A Sirgo、David Moatazedi、John P. Kenny. On average, Biomerica executives and independent directors trade stock every 61 days with the average trade being worth of 3,349$. The most recent stock trade was executed by Zackary S. Irani on 25 May 2023, trading 700 units of BMRA stock currently worth 1,113$.
biomerica, inc. (www.biomerica.com) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. the company’s products are designed to enhance health and well-being, while reducing total healthcare costs. biomerica primarily focuses on products for gastrointestinal disease, diabetes and esoteric testing. the biomerica infoods® ibs product identifies patient specific foods that when removed may alleviate an individual's ibs symptoms. this patent pending diagnostic guided therapy is designed to allow for a patient specific guided dietary regimen to improve irritable bowel syndrome (ibs) outcomes. the point-of-care product is being developed to allow physicians to perform the test in-office using a finger stick blood sample while a clinical lab version of the product will be the first for wh
Biomerica executives and other stock owners filed with the SEC include: